Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Participate in webinars on financial planning topics led by experts. These sessions are designed to enhance your knowledge and help you make informed decisions.
17,781 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Choosing between REET and RWX can shape your global real estate exposure. This guide breaks down costs, diversificati...
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Dollar Tree has reshaped its business with store expansion and a strategic divestment. This guide explains why you mi...
Planned Parenthood of Illinois agreed to a $500,000 settlement with the EEOC after an investigation found DEI practic...
Artificial intelligence stocks have powered market gains and drawn fierce interest. This guide breaks down what the d...
Dell Technologies slid sharply on a broader AI rotation, yet fundamentals remained solid, prompting Jim Cramer to cal...
Rocket Lab and AST SpaceMobile pursue different spacefrontiers, from reliable launches to space-based connectivity. T...
SoundHound AI reports a 59% rise in Q4 revenue and a narrowed EBITDA loss, yet the stock has fallen year-to-date amid...
Investors are increasingly adding blue-chip art to mainstream portfolios to diversify beyond stocks and bonds. Fracti...
Bitcoin hovers near a critical zone as traders weigh whether a floor is forming or a deeper pullback lies ahead. ETF ...
Gold and silver slid this week as geopolitical risk and higher oil costs pressured bullion, while Bitcoin bucked the ...